Gemcitabine for Marginal Zone Lymphoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00337259 |
|
Recruitment Status :
Terminated
(poor accrual and response less than expected on interim analysis)
First Posted : June 15, 2006
Last Update Posted : February 17, 2016
|
Sponsor:
Asan Medical Center
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Cheolwon Suh, Asan Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | March 2009 |
| Actual Study Completion Date : | March 2009 |